BioCentury | Jan 30, 2021
Product Development
ALS looks up as clinical pipeline explodes
Propelled by new insights into disease biology, the clinical pipeline for ALS has grown to at least 43 programs attacking the disease from a dozen different directions. With six of those programs in Phase...